Jeffrey N Motter1, Monique A Pimontel1, David Rindskopf2, Davangere P Devanand3, P Murali Doraiswamy4, Joel R Sneed5. 1. The Graduate Center, City University of New York, USA; Queens College, City University of New York, USA. 2. The Graduate Center, City University of New York, USA. 3. Columbia University and the New York State Psychiatric Institute, USA. 4. Duke Medicine and Duke Institute for Brain Sciences, USA. 5. Queens College, City University of New York, USA; Columbia University and the New York State Psychiatric Institute, USA. Electronic address: joel.sneed@qc.cuny.edu.
Abstract
OBJECTIVE: Depression is common, frequently resistant to antidepressant treatment, and associated with impairments in cognition and everyday functioning. Computerized cognitive training (CCT) paradigms offer potential to improve cognition, mood and everyday functioning, but their effectiveness is not well established. The goal of this article was to conduct a systematic review and meta-analysis to determine the efficacy of CCT in depressive disorders. METHOD: A search was conducted to identify high quality randomized controlled CCT trials per PRISMA guidelines using PsycINFO and MEDLINE with the keywords "Cognitive training" or "Cognitive remediation" or "Cognitive rehabilitation" and "Depression". 9 randomized trials for depressed adults met inclusion criteria. Effect sizes (Hedge's g) were calculated for key outcome measures of mood symptom severity, daily functioning, and cognition. A 3-level Bayesian hierarchical linear model was used to estimate effect sizes for each domain and study. Publication bias was assessed using Classic Fail Safe N's and homogeneity was evaluated using Q and I(2) indexes. RESULTS: Significant small-moderate effects for Symptom Severity (0.43) and Daily Functioning (0.72), and moderate-large effects for Attention (0.67), Working Memory (0.72), and Global Functioning (1.05) were found. No significant effects were found for Executive Functioning or Verbal Memory. Moderator variable analysis revealed decreased effect of CCT with age. Gender and concurrent medication treatment did not affect the results. LIMITATIONS: Small sample size, short duration, pseudo-specificity, and high heterogeneity for Verbal Memory measures. CONCLUSIONS: CCT is associated with improvement in depressive symptoms and everyday functioning, though produces inconsistent effects on cognition.
OBJECTIVE:Depression is common, frequently resistant to antidepressant treatment, and associated with impairments in cognition and everyday functioning. Computerized cognitive training (CCT) paradigms offer potential to improve cognition, mood and everyday functioning, but their effectiveness is not well established. The goal of this article was to conduct a systematic review and meta-analysis to determine the efficacy of CCT in depressive disorders. METHOD: A search was conducted to identify high quality randomized controlled CCT trials per PRISMA guidelines using PsycINFO and MEDLINE with the keywords "Cognitive training" or "Cognitive remediation" or "Cognitive rehabilitation" and "Depression". 9 randomized trials for depressed adults met inclusion criteria. Effect sizes (Hedge's g) were calculated for key outcome measures of mood symptom severity, daily functioning, and cognition. A 3-level Bayesian hierarchical linear model was used to estimate effect sizes for each domain and study. Publication bias was assessed using Classic Fail Safe N's and homogeneity was evaluated using Q and I(2) indexes. RESULTS: Significant small-moderate effects for Symptom Severity (0.43) and Daily Functioning (0.72), and moderate-large effects for Attention (0.67), Working Memory (0.72), and Global Functioning (1.05) were found. No significant effects were found for Executive Functioning or Verbal Memory. Moderator variable analysis revealed decreased effect of CCT with age. Gender and concurrent medication treatment did not affect the results. LIMITATIONS: Small sample size, short duration, pseudo-specificity, and high heterogeneity for Verbal Memory measures. CONCLUSIONS: CCT is associated with improvement in depressive symptoms and everyday functioning, though produces inconsistent effects on cognition.
Authors: Elizabeth W Twamley; Kelsey R Thomas; Cynthia Z Burton; Lea Vella; Dilip V Jeste; Robert K Heaton; Susan R McGurk Journal: Schizophr Res Date: 2017-08-18 Impact factor: 4.939
Authors: Katie L Bessette; Aimee J Karstens; Natania A Crane; Amy T Peters; Jonathan P Stange; Kathleen H Elverman; Sarah Shizuko Morimoto; Sara L Weisenbach; Scott A Langenecker Journal: Neuropsychol Rev Date: 2020-01-15 Impact factor: 7.444
Authors: Ivan Grahek; Amitai Shenhav; Sebastian Musslick; Ruth M Krebs; Ernst H W Koster Journal: Neurosci Biobehav Rev Date: 2019-05-27 Impact factor: 8.989
Authors: Morganne A Kraines; Summer K Peterson; Geoffrey N Tremont; Courtney Beard; Judson A Brewer; Lisa A Uebelacker Journal: Mindfulness (N Y) Date: 2022-02-16
Authors: Tamsyn E Van Rheenen; Kathryn E Lewandowski; Jessica M Lipschitz; Katherine E Burdick Journal: CNS Spectr Date: 2018-09-24 Impact factor: 3.790
Authors: C Woolf; A Lampit; Z Shahnawaz; J Sabates; L M Norrie; D Burke; S L Naismith; L Mowszowski Journal: Neuropsychol Rev Date: 2021-04-28 Impact factor: 7.444
Authors: Nils Opel; Udo Dannlowski; Janik Goltermann; Ronny Redlich; Dominik Grotegerd; Katharina Dohm; Elisabeth J Leehr; Joscha Böhnlein; Katharina Förster; Susanne Meinert; Verena Enneking; Maike Richter; Jonathan Repple; Immanuel DeVillers; Marine Kloecker; Andreas Jansen; Axel Krug; Igor Nenadić; Katharina Brosch; Tina Meller; Frederike Stein; Simon Schmitt; Marcella Rietschel; Fabian Streit; Stephanie H Witt; Andreas J Forstner; Markus M Nöthen; Bernhard T Baune; Till F M Andlauer; Tilo Kircher Journal: Neuropsychopharmacology Date: 2020-08-14 Impact factor: 7.853